keyword
https://read.qxmd.com/read/38643434/a-case-report-and-literature-review-of-iga-nephropathy-presenting-as-nephrotic-syndrome-in-polycythemia-vera
#1
JOURNAL ARTICLE
R Rajasekar, R Nandakumar, Saurav P Singhvi, Gerry George Mathew, V Jayaprakash, K Mythili
A 66-year-old non-smoker presented with a 2-week history of new-onset pedal oedema and gross haematuria. On evaluation, he was found to be hypertensive and oedematous with a haemoglobin of 19.1 g/dl, platelet count of 546,000/mm3 , and creatinine of 2.6 mg/dl. Urine examination revealed abundant RBCs with 3+ albumin on three separate occasions. His 24-h urine protein level was 3830 mg/day, with a serum cholesterol level of 303 mg/dl. Secondary erythrocytosis and thrombocytosis tests were negative...
April 21, 2024: CEN Case Reports
https://read.qxmd.com/read/38629942/high-altitude-hypoxia-exposure-inhibits-erythrophagocytosis-by-inducing-macrophage-ferroptosis-in-the-spleen
#2
JOURNAL ARTICLE
Wan-Ping Yang, Mei-Qi Li, Jie Ding, Jia-Yan Li, Gang Wu, Bao Liu, Yu-Qi Gao, Guo-Hua Wang, Qian-Qian Luo
High-altitude polycythemia (HAPC) affects individuals living at high altitudes, characterized by increased red blood cells (RBCs) production in response to hypoxic conditions. The exact mechanisms behind HAPC are not fully understood. We utilized a mouse model exposed to hypobaric hypoxia (HH), replicating the environmental conditions experienced at 6000 m above sea level, coupled with in vitro analysis of primary splenic macrophages under 1% O2 to investigate these mechanisms. Our findings indicate that HH significantly boosts erythropoiesis, leading to erythrocytosis and splenic changes, including initial contraction to splenomegaly over 14 days...
April 17, 2024: ELife
https://read.qxmd.com/read/38629639/novel-germline-jak2-r715t-mutation-causing-pv-like-erythrocytosis-in-3-generations-amelioration-by-ropeg-interferon
#3
JOURNAL ARTICLE
Jihyun Song, Lucie Lanikova, Soo Jin Kim, Nicolas Papadopoulos, Jessica Meznarich, Stefan N Constantinescu, Brynn Parsegov, Jaroslav F Prchal, Josef T Prchal
Polycythemia vera (PV) is a clonal disorder arising from the acquired somatic mutations of the JAK2 gene, including JAK2V617F or several others in exon 12. A 38-year-old female had a stroke at age 32 and found to have elevated hemoglobin, normal leukocytes, normal platelets, and tested negative for JAK2V617F and exon 12 mutations. Next generation sequencing revealed a novel mutation: JAK2R715T in the pseudokinase domain (JH2) at 47.5%. Its presence in her nail DNA confirmed a germline origin. Her mother and her son similarly had erythrocytosis and a JAK2R715T mutation...
April 17, 2024: American Journal of Hematology
https://read.qxmd.com/read/38621632/erythrocytosis-and-ckd
#4
REVIEW
Mabel Aoun, Michel Jadoul, Hans-Joachim Anders
Erythrocytosis or polycythemia is defined as an increase in red blood cell concentration above the age- and sex-specific normal levels. Unlike anemia that is very common in chronic kidney disease (CKD) patients, erythrocytosis is less frequent but requires specific understanding by healthcare professionals in order to provide the best care. Erythrocytosis, especially when undiagnosed and untreated, can lead to serious thrombotic events and higher mortality. Classical causes of erythrocytosis associated with CKD include cystic kidney diseases, kidney or other erythropoietin-secreting neoplasms, high-altitude renal syndrome, overdosage of erythropoietin-stimulating agents, androgen therapy, heavy smoking, chronic lung disease, obstructive sleep apnea, IgA nephropathy, post-kidney transplant erythrocytosis, renal artery stenosis and congenital etiologies...
April 13, 2024: American Journal of Kidney Diseases
https://read.qxmd.com/read/38592500/bibliometric-analysis-of-worldwide-research-on-polycythemia-vera-in-the-21st-century
#5
REVIEW
Zhengjiu Cui, Fei Luo, Yuan Zhang, Juanjuan Diao, Yueli Pan
Polycythemia vera (PV) is a myeloproliferative tumor with low incidence and complex symptoms, affecting patients' quality of life and shortening their life span. Since the beginning of the 21st century, there has been an update but a need for uniform consensus regarding diagnosing and treating PV. With the continued interest of researchers in this field, a bibliometric study of PV is necessary. This paper aims to analyze articles on PV through bibliometric software to provide collaborative information and new ideas for researchers in this field...
April 9, 2024: Annals of Hematology
https://read.qxmd.com/read/38585007/tnf-%C3%AE-is-a-predictive-marker-in-distinguishing-myeloproliferative-neoplasm-and-idiopathic-erythrocytosis-thrombocytosis-development-and-validation-of-a-non-invasive-diagnostic-model
#6
JOURNAL ARTICLE
Zhenhao Wang, Yu Mei, Zhuming Yang, Qiang Gao, Hao Xu, Zhiqiang Han, Zhenya Hong
PURPOSE: Philadelphia-chromosome negative myeloproliferative neoplasms (MPN) exhibit phenotypic similarities with JAK/STAT-unmutated idiopathic erythrocytosis and thrombocytosis (IE/IT). We aimed to develop a clinical diagnostic model to discern MPN and IE/IT. METHODS: A retrospective study was performed on 77 MPN patients and 32 IE/IT patients in our center from January 2018 to December 2023. We investigated the role of hemogram, cytokine and spleen size in differentiating MPN and IE/IT among newly onset erythrocytosis and thrombocytosis patients...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38579024/jakcalc-a-machine-learning-approach-to-rationalized-jak2-testing-in-patients-with-elevated-hemoglobin-levels
#7
JOURNAL ARTICLE
Fatos Dilan Koseoglu, Fatma Keklik Karadag, Hale Bulbul, Erdem Ugur Alici, Berk Ozyilmaz, Taha Resid Ozdemir
The demand for Janus Kinase-2 (JAK2) testing has been disproportionate to the low yield of positive results, which highlights the need for more discerning test strategies. The aim of this study is to introduce an artificial intelligence application as a more rational approach for testing JAK2 mutations in cases of erythrocytosis. Test results were sourced from samples sent to a tertiary hospital's genetic laboratory between 2017 and 2023, meeting 2016 World Health Organization criteria for JAK2V617F mutation testing...
April 5, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38568469/diagnostic-approaches-to-investigate-jak2-unmutated-erythrocytosis-based-on-a-single-tertiary-center-experience
#8
JOURNAL ARTICLE
Youngeun Lee, Soo Hyun Seo, Jinho Kim, Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Kyoung Un Park, Sang Mee Hwang
INTRODUCTION: Erythrocytosis is attributed to various clinical and molecular factors. Many cases of JAK2-unmutated erythrocytosis remain undiagnosed. We investigated the characteristics and causes of JAK2-unmutated erythrocytosis. METHODS: We assessed the clinical and laboratory results of patients with erythrocytosis without JAK2 mutations and performed targeted next-generation sequencing (NGS) panels for somatic and germline mutations. RESULTS: In total, 117 patients with JAK2-unmutated erythrocytosis were included...
April 3, 2024: Molecular Diagnosis & Therapy
https://read.qxmd.com/read/38568374/two-novel-genetic-variants-involved-in-the-oxygen-sensing-pathway-in-jak2-unmutated-erythrocytosis
#9
JOURNAL ARTICLE
Qiang Ma, Ronghua Hu, Wuhan Hui, Hong Zhao, Dongmei Zou, Yan Liu, Wanling Sun
JAK2-unmutated erythrocytosis or non-polycythemia vera erythrocytosis is a rare condition comprising both acquired and hereditary forms. Although acquired erythrocytosis has been well-studied, hereditary erythrocytosis remains poorly studied. Genetic alterations associated with hereditary erythrocytosis include mutations in erythropoietin receptor and erythropoietin (EPO), altered oxygen affinity mutations, and variants associated with the oxygen-sensing pathway. We established a molecular diagnostic approach based on these genes and retrospectively evaluated...
April 3, 2024: Biochemical Genetics
https://read.qxmd.com/read/38561874/secondary-polycythemia-and-non-islet-cell-tumor-induced-hypoglycemia-in-advanced-hepatocellular-carcinoma-a-case-report
#10
JOURNAL ARTICLE
Maria Satya Paramitha, Dekta Filantropi Esa, Ni Made Hustrini, Nadia Ayu Mulansari, Irsan Hasan, Agnes Stephanie Harahap
Continuously holding its position as the sixth most common cause of cancer and the third leading cause of cancer death, globally, Hepatocellular Carcinoma (HCC) remains as a healthcare priority. Production of various substances may result into systemic or metabolic complications, often known as paraneoplastic phenomena of HCC. A 56-year-old male with history of untreated chronic hepatitis B arrived with generalized weakness and intermittent headache in the last two days prior to admission. Laboratory findings demonstrated elevated hemoglobin (20...
January 2024: Acta Medica Indonesiana
https://read.qxmd.com/read/38554424/extensive-hepatic-infarction-due-to-polycythemia-vera
#11
JOURNAL ARTICLE
Kazuhiro Furukawa, Fumihiro Urano, Shozo Okamura, Hiroki Kawashima
Polycythemia vera (PV) is one of the three BCR-ABL1-negative myeloproliferative neoplasms characterized by activating mutations in JAK2, which clinically presents as erythrocytosis and has an increased risk of both thromboembolic events and progression to myelofibrosis and acute myeloid leukemia. Splanchnic vein thrombosis is a rare manifestation of venous thromboembolism involving one or more abdominal vessels and is strongly associated with PV. We herein report a case in which hepatic infarction due to PV was saved by conservative treatment...
March 29, 2024: Journal of Gastrointestinal and Liver Diseases: JGLD
https://read.qxmd.com/read/38554124/are-coagulation-profiles-in-andean-highlanders-with-excessive-erythrocytosis-favouring-hypercoagulability
#12
JOURNAL ARTICLE
Benoit Champigneulle, François Caton, Landry Seyve, Émeric Stauffer, Aurélien Pichon, Julien V Brugniaux, Michael Furian, Ivan Hancco, Blandine Deschamps, Lars Kaestner, Paul Robach, Philippe Connes, Pierre Bouzat, Benoit Polack, Raphael Marlu, Samuel Verges
Chronic mountain sickness is a maladaptive syndrome that affects individuals living permanently at high altitude and is characterized primarily by excessive erythrocytosis (EE). Recent results concerning the impact of EE in Andean highlanders on clotting and the possible promotion of hypercoagulability, which can lead to thrombosis, were contradictory. We assessed the coagulation profiles of Andeans highlanders with and without excessive erythrocytosis (EE+ and EE-). Blood samples were collected from 30 EE+ and 15 EE- in La Rinconada (Peru, 5100-5300 m a...
March 30, 2024: Experimental Physiology
https://read.qxmd.com/read/38536657/increased-risk-of-erythrocytosis-in-men-with-type-2-diabetes-treated-with-combined-sodium-glucose-cotransporter-2-inhibitor-and-testosterone-replacement-therapy
#13
JOURNAL ARTICLE
A R Gosmanov, D E Gemoets, K A Schumacher
PURPOSE: In clinical trials, sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and testosterone replacement therapy (TRT) were shown to stimulate red blood cell production. Little is known if combination therapy poses risk of erythrocytosis in real world clinical practice. METHODS: This was a retrospective nationwide cohort study of US Veterans with type 2 diabetes (T2D) and baseline hematocrit between 38 and 50% who were prescribed SGLT-2i and/or TRT between 3/2013 and 10/2022 and had adequate adherence based on the proportion of days covered > 80%...
March 27, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38508605/myomatous-erythrocytosis-syndrome-a-uterine-fibroid-associated-with-polycythaemia
#14
JOURNAL ARTICLE
Faisal Ansari, Talal Al Assil, Mohammad Omaira, Anna V Hoekstra
Myomatous erythrocytosis syndrome (MES) is a rare form of secondary erythrocytosis seen with myomas. Here, we present a case of a postmenopausal, nulliparous woman in her 50s incidentally found to have asymptomatic erythrocytosis on routine laboratory work. She was found to have an 18.5 cm myoma and after surgical resection, the patient's haematological values returned to normal ranges after a few weeks. This established the diagnosis as MES. The aetiology of MES continues to remain unknown but is most likely caused by an autonomous production of erythropoietin from the myomatous tissue...
March 19, 2024: BMJ Case Reports
https://read.qxmd.com/read/38468832/coexistence-of-multiple-gene-variants-in-some-patients-with-erythrocytoses
#15
JOURNAL ARTICLE
Andrea Benetti, Irene Bertozzi, Giulio Ceolotto, Irene Cortella, Daniela Regazzo, Giacomo Biagetti, Elisabetta Cosi, Maria Luigia Randi
BACKGROUND: Erythrocytosis is a relatively common condition; however, a large proportion of these patients (70%) remain without a clear etiologic explanation. METHODS: We set up a targeted NGS panel for patients with erythrocytosis, and 118 sporadic patients with idiopathic erythrocytosis were studied. RESULTS: In 40 (34%) patients, no variant was found, while in 78 (66%), we identified at least one germinal variant; 55 patients (70.5%) had 1 altered gene, 18 (23%) had 2 alterations, and 5 (6...
2024: Mediterranean Journal of Hematology and Infectious Diseases
https://read.qxmd.com/read/38464426/incidence-risk-factors-and-outcomes-of-posttransplant-erythrocytosis-among-simultaneous-pancreas-kidney-transplant-recipients
#16
JOURNAL ARTICLE
Mina L Gibes, Brad C Astor, Jon Odorico, Didier Mandelbrot, Sandesh Parajuli
BACKGROUND: Posttransplant erythrocytosis (PTE) is a well-known complication of kidney transplantation. However, the risk and outcomes of PTE among simultaneous pancreas-kidney transplant (SPKT) recipients are poorly described. METHODS: We analyzed all SPKT recipients at our center between 1998 and 2021. PTE was defined as at least 2 consecutive hematocrit levels of >51% within the first 2 y of transplant. Controls were selected at a ratio of 3:1 at the time of PTE occurrence using event density sampling...
April 2024: Transplantation Direct
https://read.qxmd.com/read/38452480/extreme-erythrocytosis-in-a-cat-reverts-after-short-term-treatment-with-hydroxyurea-and-the-cat-remains-healthy-for-years
#17
JOURNAL ARTICLE
Jessica Billström-Saxon, Urs Giger
OBJECTIVE: This case report describes a cat with severe erythrocytosis (Hct, 80%), which after initial treatment with hydroxyurea has gone into remission for over 3 years. ANIMAL: A 1-year-old neutered male American Maine Coon crossbred cat. CLINICAL PRESENTATION, PROGRESSION, AND PROCEDURES: A 1-year-old neutered male American Maine Coon crossbred domestic cat was presented with acute neurologic signs, systolic heart murmur, and extreme erythrocytosis (Hct, 80%; normal interval, 30% to 48%)...
March 7, 2024: Journal of the American Veterinary Medical Association
https://read.qxmd.com/read/38448860/chronic-obstructive-pulmonary-disease-burden-grades-and-erythrocytosis-at-a-tertiary-hospital-in-western-uganda
#18
JOURNAL ARTICLE
Amon Banturaki, Dalton Kambale Munyambalu, Dickson Kajoba, Verah Bella Onchoke, Alina Peris, Prosper Ryamugwiza, Jacinto Amandua, Kingsley Akaba
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide among people over 40 years of age, and erythrocytosis is one of the major complications associated with increased mortality among COPD patients. The study aimed to determine the proportion of COPD, associated factors, and the burden of erythrocytosis among COPD participants. METHODS AND MATERIALS: A descriptive cross-sectional study design was used. A consecutive sampling technique was used to obtain study participants at the Fort Portal Regional Referral Hospital outpatient clinic...
March 6, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38436283/central-retinal-artery-occlusion-in-young-adults-at-high-altitude-thin-air-high-stakes
#19
JOURNAL ARTICLE
Vipin Rana, Pradeep Kumar, Sandeepan Bandopadhyay, Vijay K Sharma, Meenu Dangi, Dattakiran Joshi, Sanjay Kumar Mishra, Satyabrat Srikumar, V A Arun
Rana, Vipin, Pradeep Kumar, Sandeepan Bandopadhyay, Vijay K. Sharma, Meenu Dangi, Dattakiran Joshi, Sanjay Kumar Mishra, Satyabrat Srikumar, and V.A. Arun. Central retinal artery occlusion in young adults at high altitude: thin air, high stakes. High Alt Med Biol. 00:000-000, 2024.-We present five cases of young security personnel who were posted at high altitude (HA) for a duration of at least 6 months and presented with a sudden decrease of vision in one eye. The diagnosis of central retinal artery occlusion (CRAO) was made in all patients...
March 1, 2024: High Altitude Medicine & Biology
https://read.qxmd.com/read/38419349/a-rare-case-of-tempi-syndrome-telangiectasias-erythrocytosis-monoclonal-gammopathy-and-ascites-associated-with-igm-monoclonal-gammopathy
#20
JOURNAL ARTICLE
Stavroula Asimakopoulou, Panagiotis Malandrakis, Aikaterini Kamiliou, Maria Gavriatopoulou, Konstantina Bafa, Vaios Samaras, Amalia Anastasopoulou, Eleni Variami, Eleftheria Lakiotaki, Penelope Korkolopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Evangelos Cholongitas
No abstract text is available yet for this article.
February 28, 2024: Leukemia & Lymphoma
keyword
keyword
30600
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.